Pharmacokinetics of new oral hepatitis C antiviral drugs.
about
Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizonCost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individuals.Update on HIV/HCV coinfection.Drug interactions with new hepatitis C oral drugs.Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.Prevention and management of treatment failure to new oral hepatitis C drugs.Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C.New hepatitis C therapies for special patient populations.
P2860
Q26773201-66C79733-C5DD-49C0-800A-D4C039FB61DDQ33831652-8DC2E7ED-B39A-4EB8-8C4E-151196B345CCQ38119893-14126169-1607-4497-A9B5-862BD1CDF203Q38305640-B82097DF-72AC-4A6D-AE86-77D37EBF1A0EQ38554604-A35B7D20-59A2-4074-8ECA-F240C5D6F39AQ38826624-A010FA7A-8D04-41F1-8268-476837867F15Q38929010-FE62BE59-F54F-4D54-805A-01168FBE2ABBQ40899794-8F8FE9A8-AF9E-490B-9B55-315FF1F761D3
P2860
Pharmacokinetics of new oral hepatitis C antiviral drugs.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Pharmacokinetics of new oral hepatitis C antiviral drugs.
@ast
Pharmacokinetics of new oral hepatitis C antiviral drugs.
@en
type
label
Pharmacokinetics of new oral hepatitis C antiviral drugs.
@ast
Pharmacokinetics of new oral hepatitis C antiviral drugs.
@en
prefLabel
Pharmacokinetics of new oral hepatitis C antiviral drugs.
@ast
Pharmacokinetics of new oral hepatitis C antiviral drugs.
@en
P2093
P2860
P1476
Pharmacokinetics of new oral hepatitis C antiviral drugs.
@en
P2093
Eugenia Vispo
Pablo Barreiro
Vicente Soriano
P2860
P356
10.1517/17425255.2013.729577
P407
P577
2012-10-25T00:00:00Z